Publications by authors named "Palomares P"
Article Synopsis
- The study focuses on the experiences and outcomes of treating 78 patients with IMRT and SBRT using the RefleXion X1 system during its first year in clinical use.
- Main treatment sites included the head and neck (63%) and pelvis (23%), with treatment times and machine performance metrics showing favorable results, including a 92% machine uptime.
- Patient satisfaction was high for machine operation and quality assurance, but there were identified areas for improvement in the treatment workflow for therapists.
Objectives: Viral factors are considered the best predictors of response to treatment for chronic hepatitis C (CHC), but genetic factors are known to have an important role in this respect. This paper investigates the relationships among the host genetic factors HLA and IL28B, viral factors, and the outcome of combination therapy.
Methods: A multicenter retrospective cohort of 428 previously untreated CHC patients was treated with pegylated interferon/ribavirin (pegIFN/RBV) for 48 weeks.
Serous retinal detachment as a presenting feature of chronic myelogenous leukemia.
Retin Cases Brief Rep
November 2014
Purpose: The purpose of this study was to report a case of diffuse unilateral retinal detachment as an initial symptom of chronic myelogenous leukemia in a 35-year-old woman.
Methods: This is a case report of a 35-year-old white woman who presented with painless acute visual loss in her left eye.
Results: A 35-year-old white woman presented with acute visual loss in her left eye.
[Low dose photodynamic therapy for chronic central serous chorioretinopathy].
Arch Soc Esp Oftalmol
September 2008
[Intravitreal injection of bevacizumab (Avastin) for retinal angiomatous proliferation].
Arch Soc Esp Oftalmol
January 2008
Clinical Case: An 81-year-old man presented with stage 2 retinal angiomatous proliferation (RAP) as identified by fluorescein angiography and optical coherence tomography (OCT), and was shown to have a visual acuity (VA) of 20/40. One week after an intravitreal injection of bevacizumab (1.25 mg) the VA improved to 20/25, and the OCT showed a reduction of both intraretinal edema and pigment epithelium detachment.
View Article and Find Full Text PDFPurpose: To determine whether bevacizumab may improve anatomic and visual outcomes in patients with ocular ischemic syndrome (OIS).
Design: Interventional case reports.
Methods: Two patients with OIS presenting with unilateral ocular pain, iris neovascularization, and macular edema.
The impedance spectroscopy technique (IST) was used for studying the effect of a 0.5 T magnetic field on the electrical properties of whole human blood. A Solartron SI 1260 spectrometer was used to measure the impedance spectra of magnetic field exposed blood samples compared to non-exposed samples.
View Article and Find Full Text PDF